These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28587059)

  • 21. Chemotherapy-induced neuropathy: A comprehensive survey.
    Miltenburg NC; Boogerd W
    Cancer Treat Rev; 2014 Aug; 40(7):872-82. PubMed ID: 24830939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial.
    Hirayama Y; Ishitani K; Sato Y; Iyama S; Takada K; Murase K; Kuroda H; Nagamachi Y; Konuma Y; Fujimi A; Sagawa T; Ono K; Horiguchi H; Terui T; Koike K; Kusakabe T; Sato T; Takimoto R; Kobune M; Kato J
    Int J Clin Oncol; 2015 Oct; 20(5):866-71. PubMed ID: 25762165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid-soluble nutrient status of healthy Omani school children before and after intervention with oily fish meal or re-esterified triacylglycerol fish oil.
    Al-Ghannami SS; Sedlak E; Hussein IS; Min Y; Al-Shmmkhi SM; Al-Oufi HS; Al-Mazroui A; Ghebremeskel K
    Nutrition; 2016 Jan; 32(1):73-8. PubMed ID: 26481332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Updating your peripheral neuropathy "know-how".
    Marrs J; Newton S
    Clin J Oncol Nurs; 2003; 7(3):299-303. PubMed ID: 12793336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prechemotherapy Touch Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients with Colorectal Cancer.
    Wang XS; Shi Q; Dougherty PM; Eng C; Mendoza TR; Williams LA; Fogelman DR; Cleeland CS
    Oncology; 2016; 90(3):127-35. PubMed ID: 26882477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The contribution of diet and sun exposure to the nutritional status of vitamin D in elderly Spanish women: the five countries study (OPTIFORD Project)].
    Rodríguez Sangrador M; Beltrán de Miguel B; Quintanilla Murillas L; Cuadrado Vives C; Moreiras Tuny O
    Nutr Hosp; 2008; 23(6):567-76. PubMed ID: 19132265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lenalidomide in patients with chemotherapy-induced polyneuropathy and relapsed or refractory multiple myeloma: results from a single-centre prospective study.
    Briani C; Torre CD; Campagnolo M; Lucchetta M; Berno T; Candiotto L; Padua L; Ermani M; Cavaletti G; Zambello R
    J Peripher Nerv Syst; 2013 Mar; 18(1):19-24. PubMed ID: 23521639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy.
    Bakogeorgos M; Georgoulias V
    Expert Rev Anticancer Ther; 2017 Nov; 17(11):1045-1060. PubMed ID: 28868935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives.
    Ewertz M; Qvortrup C; Eckhoff L
    Acta Oncol; 2015 May; 54(5):587-91. PubMed ID: 25751757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS).
    Binda D; Vanhoutte EK; Cavaletti G; Cornblath DR; Postma TJ; Frigeni B; Alberti P; Bruna J; Velasco R; Argyriou AA; Kalofonos HP; Psimaras D; Ricard D; Pace A; Galiè E; Briani C; Dalla Torre C; Lalisang RI; Boogerd W; Brandsma D; Koeppen S; Hense J; Storey D; Kerrigan S; Schenone A; Fabbri S; Rossi E; Valsecchi MG; Faber CG; Merkies IS; ; Galimberti S; Lanzani F; Mattavelli L; Piatti ML; Bidoli P; Cazzaniga M; Cortinovis D; Lucchetta M; Campagnolo M; Bakkers M; Brouwer B; Boogerd W; Grant R; Reni L; Piras B; Pessino A; Padua L; Granata G; Leandri M; Ghignotti I; Plasmati R; Pastorelli F; Heimans JJ; Eurelings M; Meijer RJ; Grisold W; Lindeck Pozza E; Mazzeo A; Toscano A; Russo M; Tomasello C; Altavilla G; Penas Prado M; Dominguez Gonzalez C; Dorsey SG
    Eur J Cancer; 2013 Sep; 49(13):2910-8. PubMed ID: 23668917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship of vitamin D status to risk of cardiovascular disease and mortality.
    Skaaby T
    Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy.
    Schloss J; Colosimo M; Vitetta L
    Asia Pac J Oncol Nurs; 2016; 3(1):73-85. PubMed ID: 27981142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depletion of nerve growth factor in chemotherapy-induced peripheral neuropathy associated with hematologic malignancies.
    Youk J; Kim YS; Lim JA; Shin DY; Koh Y; Lee ST; Kim I
    PLoS One; 2017; 12(8):e0183491. PubMed ID: 28827818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy-induced peripheral neuropathy: assessment of oncology nurses' knowledge and practice.
    Binner M; Ross D; Browner I
    Oncol Nurs Forum; 2011 Jul; 38(4):448-54. PubMed ID: 21708535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is advanced age associated with increased incidence and severity of chemotherapy-induced peripheral neuropathy?
    Argyriou AA; Polychronopoulos P; Koutras A; Iconomou G; Gourzis P; Assimakopoulos K; Kalofonos HP; Chroni E
    Support Care Cancer; 2006 Mar; 14(3):223-9. PubMed ID: 16021477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera
    Desideri I; Francolini G; Becherini C; Terziani F; Delli Paoli C; Olmetto E; Loi M; Perna M; Meattini I; Scotti V; Greto D; Bonomo P; Sulprizio S; Livi L
    Med Oncol; 2017 Mar; 34(3):46. PubMed ID: 28205185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic field therapy in patients with cytostatics-induced polyneuropathy: A prospective randomized placebo-controlled phase-III study.
    Rick O; von Hehn U; Mikus E; Dertinger H; Geiger G
    Bioelectromagnetics; 2017 Feb; 38(2):85-94. PubMed ID: 27657350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives.
    Poupon L; Kerckhove N; Vein J; Lamoine S; Authier N; Busserolles J; Balayssac D
    Expert Opin Drug Saf; 2015 Aug; 14(8):1269-82. PubMed ID: 26058312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nursing knowledge, practice patterns, and learning preferences regarding chemotherapy-induced peripheral neuropathy.
    Smith EM; Campbell G; Tofthagen C; Kottschade L; Collins ML; Warton C; Ghosh B; Ronis DL; Mallory GA; Visovsky C
    Oncol Nurs Forum; 2014 Nov; 41(6):669-79. PubMed ID: 25355022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy-induced peripheral neuropathy: prevention and treatment.
    Pachman DR; Barton DL; Watson JC; Loprinzi CL
    Clin Pharmacol Ther; 2011 Sep; 90(3):377-87. PubMed ID: 21814197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.